Cargando…
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076000/ https://www.ncbi.nlm.nih.gov/pubmed/37030318 http://dx.doi.org/10.1016/S1473-3099(23)00208-6 |
| _version_ | 1785020040135835648 |
|---|---|
| author | Solera, Javier T Arbol, Berta G Ferreira, Victor H Kurtesi, Alexandra Hu, Queenie Ierullo, Matthew Valverde-Zuniga, Adriana Raslan, Ismail Nasir, Asma Grizales, Clara Hardy, W Rod Kulasingam, Vathany Gingras, Anne-Claude Humar, Atul Kumar, Deepali |
| author_facet | Solera, Javier T Arbol, Berta G Ferreira, Victor H Kurtesi, Alexandra Hu, Queenie Ierullo, Matthew Valverde-Zuniga, Adriana Raslan, Ismail Nasir, Asma Grizales, Clara Hardy, W Rod Kulasingam, Vathany Gingras, Anne-Claude Humar, Atul Kumar, Deepali |
| author_sort | Solera, Javier T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10076000 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100760002023-04-06 Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab Solera, Javier T Arbol, Berta G Ferreira, Victor H Kurtesi, Alexandra Hu, Queenie Ierullo, Matthew Valverde-Zuniga, Adriana Raslan, Ismail Nasir, Asma Grizales, Clara Hardy, W Rod Kulasingam, Vathany Gingras, Anne-Claude Humar, Atul Kumar, Deepali Lancet Infect Dis Correspondence Elsevier Ltd. 2023-05 2023-04-05 /pmc/articles/PMC10076000/ /pubmed/37030318 http://dx.doi.org/10.1016/S1473-3099(23)00208-6 Text en © 2023 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Solera, Javier T Arbol, Berta G Ferreira, Victor H Kurtesi, Alexandra Hu, Queenie Ierullo, Matthew Valverde-Zuniga, Adriana Raslan, Ismail Nasir, Asma Grizales, Clara Hardy, W Rod Kulasingam, Vathany Gingras, Anne-Claude Humar, Atul Kumar, Deepali Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title | Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title_full | Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title_fullStr | Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title_full_unstemmed | Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title_short | Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| title_sort | differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076000/ https://www.ncbi.nlm.nih.gov/pubmed/37030318 http://dx.doi.org/10.1016/S1473-3099(23)00208-6 |
| work_keys_str_mv | AT solerajaviert differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT arbolbertag differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT ferreiravictorh differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT kurtesialexandra differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT huqueenie differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT ierullomatthew differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT valverdezunigaadriana differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT raslanismail differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT nasirasma differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT grizalesclara differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT hardywrod differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT kulasingamvathany differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT gingrasanneclaude differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT humaratul differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab AT kumardeepali differentialserumneutralisationofomicronsublineagesinpatientsreceivingprophylaxiswithtixagevimabcilgavimab |